The Antitrust Week In Review
Here are some of the developments in antitrust news this past week that we found interesting and are following.
Viatris Agrees to Settle EpiPen Antitrust Litigation for $264 Million
. Viatris, the drugmaker previously known as Mylan, announced that it had agreed to pay $264 million to settle a class-action lawsuit that alleged the company was involved in an illegal scheme to monopolize the market for...